Condition: Celiac Disease · Sponsor: Barinthus Biotherapeutics
GLU001 is a first-in-human clinical trial to assess the safety and tolerability of VTP-1000 for adults with celiac disease. This trial will assess VTP-1000 at various dose levels compared to placebo in a single ascending dose (SAD) and multiple ascending dose (MAD) format. Participants will be followed for a short period of time to assess the impact of VTP-1000 on their immune system (Adverse events, reactions in the blood, and physical exam differences). Participants enrolled in the MAD portion of the trial will undergo a gluten challenge to assess the impact exposure to gluten has on participants after administration of VTP-1000.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Parexel EPCU LA | Los Angeles, California, United States | Recruiting |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | Recruiting |
| Jacksonville Center for Clinical Research | Jacksonville, Florida, United States | Recruiting |
| GCP Research | St. Petersburg, Florida, United States | Recruiting |
| Parexel EPCU Baltimore | Baltimore, Maryland, United States | Recruiting |
| Clinical Research Institute of Michigan | Clinton Township, Michigan, United States | Recruiting |
| West Michigan Clinical Research Center | Wyoming, Michigan, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| NYU Langone - Gastroenterology Associates | New York, New York, United States | Recruiting |
| North Carolina Clinical Research | Raleigh, North Carolina, United States | Recruiting |
| Centricity Research | Columbus, Ohio, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06310291